1.CONCLUSION: HBV DNA sequences were able to pass through the zona and oolemma to enter into oocytes and integrate into their chromosomes.
结论：HBVDNA序列能够通过卵母细胞的透明带和细胞膜，进入卵母细胞内并整合到卵母细胞染色体上。
2.Objective: To observe the change of HBV DNA level in the sera of patients with chronic viral hepatic disease and its clinical significance.
前言：目的：探讨慢性乙型肝病患者血清HBVDNA水平变化在慢性乙型肝病发生发展中的作用及临床意义。
3.dynamic observation of HBV-DNA level, help to determine young women with chronic hepatitis B Pregnancy after liver disease degree.
动态观察HBV-DNA水平，有助于判断慢性乙型肝炎青年女性妊娠后肝脏病变程度。
4.AIM To explore the relationship between the serum markers of hepatitis B virus (HBV M)and HBV DNA in human hepatocellular carcinoma.
目的为了探讨肝癌患者血清中HBV标志物与HBV-DNA之间的相关性。
5.Occult HBV infection is characterized by the persistence of HBV DNA in the liver of inpiduals negative for HBV surface antigen (HBsAg).
隐性乙肝病毒（HBV）感染的特点是人体肝内乙肝病毒（HBV）DNA持续存在而HBV表面抗原（HBsAg）阴性。
6.While Hepatitis B Test, commonly known as HBV test and HBV-DNA test, has been canceled, aminotransferase test still has to be done.
二是取消乙肝项目检测，即俗称的“乙肝五项”和HBV-DNA检测，继续保留转氨酶检测作为体检项目。
7.In defining this cohort we discovered a subset of patients that presented with no detectable HBV DNA over the entire 8 year period.
在确定这一群体中，我们发现没有检测到HBVDNA的患者提出，在整个8年期间的一个子集。
8.Joint detection of Hepatitis B serological markers and HBV DNA can provide accurate and reliable data for clinical diagnosis.
乙肝血清标志物与HBV-DNA检测的结合能更好地为临床提供准确可靠的诊断数据。
9.ALT level, serum HBV DNA, and hepatitis B serology markers were measured at regular intervals, the adverse events were recorded.
分别观察两组血清生化学指标、HBVDNA水平、HBV血清学标志物变化以及不良反应的发生率。
10.CONCLUSIONS: Significant hepatic fibrosis and necroinflammation can reliably be predicted using routinely checked tests and HBV DNA levels.
使用常规检查和HBVDNA水平可以很可靠地预测严重的肝纤维化和炎症。